Abstract
Posterior reversible encephalopathy syndrome (PRES)or Reversible posterior leukoencephalopathy syndrome (RPLS) is a neurological complication associated with various illnesses and medications(including rheumatological illnesses and their medications). Cyclosporine is the drug which is most commonly implicated in the causation of this condition. The authors report a 6 year old patient with systemic onset juvenile idiopathic arthritis (SoJIA) with macrophage activation syndrome who developed PRES during treatment with pulse methylprednsiolone therapy. In view of persitent SoJIA disease activity, the child was subsequently treated with Cyclosporine. The child made a complete neurological recovery. This case report highlights that, in accordance with recent literature, PRES is a complication of a unique set of conditions comprising of inflammation, hypertension, immunosupression and nephropathy in different degrees and does not necessarily preclude the use of drugs implicated as inciting agents. This has important implications in rheumatology where cyclosporine is a life saving medication used in macrophage activation syndrome.
References
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol. 2008;29:1036–42.
Duncan R, Hadley D, Bone I, Symonds EM, Worthington BS, Rubin PC. Blindness in eclampsia: CT and MR imaging. J Neurol Neurosurg Psychiatry. 1989;52:899–902.
Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45:1078–83.
Min L, Zwerling J, Ocava LC, Chen IH, Putterman C. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum. 2006;35:388–95.
Henter JI, Horne A, Arico M, et al. HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.
Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology. 2009;51:373–83.
Roth C, Ferbert A. Posterior reversible encephalopathy syndrome—long-term follow-up. J Neurol Neurosurg Psychiatry. 2010;81:773–7.
Buddiga P, Pedra-nobre M, Jyonouchi H, Wolff A, Bielory L. Macrophage activation syndrome associated with posterior syndrome reversible encephalopathy. J Allergy Clin Immunol. 2005;115:S17.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, S., Rajam, L. Posterior Reversible Encephalopathy Syndrome (PRES/RPLS) During Pulse Steroid Therapy in Macrophage Activation Syndrome. Indian J Pediatr 78, 1002–1004 (2011). https://doi.org/10.1007/s12098-011-0368-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-011-0368-2